Lampiran 1
DAFTAR RIWAYAT HIDUP
Nama
: Dasta Senorita Ginting
Tempat/Tanggal Lahir
: Medan/01 Desember 1994
Agama
: Kristen Protestan
Alamat
: Jalan Bunga Sedap Malam IX No.9, Medan
Riwayat Pendidikan
:1. TK Swasta Katholik Assisi (1999-2000)
2. SD Swasta St. Petrus (2000-2006)
3. SMP Negeri 1 Medan (2006-2009)
4. SMA Negeri 15 Medan (2009-2012)
5.Fakultas
Kedokteran
Universitas
Sumatera Utara (2012-sekarang)
Riwayat Pelatihan
:1. Get Together SCORE PEMA FK USU
2013
2. Seminar dan Workshop Basic Life Support
& Traumatology
TBM PEMA FK USU
2013
3. Peserta Penerimaan Mahasiswa Baru
(PMB) FK USU 2012
ANGGARAN BIAYA PENELITIAN
1. Persiapan Proposal
Rincian
Jumlah
Harga Satuan
Total
Administrasi survei awal
penelitian di RSUP H. Adam
Malik
Rp 75.000,00
Rp 75.000,00
Print proposal awal
50
Rp 500,00
Rp 25.000,00
Print proposal revisi
30
Rp 500,00
Rp 15.000,00
Copy dan Jilid proposal awal
5
Rp 10.500,00
Rp 52.500,00
Copy dan Jilid proposal revisi
5
Rp 7.500,00
Rp 37.500,00
Total
Rp 205.000,00
2. Taksasi Pengumpulan Data
Biaya administrasi
pengambilan data di RSUP H.
Adam Malik Medan
Rp
200.000,00
Rp 200.000,00
Total
Rp 200.000,00
3. Taksasi Analisis data dan revisi
Tinta print
1
Rp 85.000,00
Rp 85.000,00
Kertas A4
1
Rp 30.000,00
Rp 30.000,00
Copy dan Jilid KTI softcover
5
Rp 7.000,00
Rp 35.000,00
Jilid KTI hardcover
5
Rp 20.000,00
Rp 100.000,00
Total
Rp 250.000,00
4. Transportasi
Rp 200.000,00
Lampiran
Frequencies
[DataSet1] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Dasta Data.sav
Frequency Table
Statistics
27 27 27 27 27
0 0 0 0 0
1.3704 48.52 4.2963 2.44 1.30 1.0000 53.00 5.0000 2.00 1.00
1.00 19 1.00 1 1
2.00 76 7.00 6 2
Valid Missing N
Mean Median Minimum Maximum
Jenis
Kelamin Usia Kategori Usia
Bakteri Penyebab
VAP Onset
Jenis Kelamin
17 63.0 63.0 63.0 10 37.0 37.0 100.0 27 100.0 100.0
laki-laki perempuan Total Valid
Frequency Percent Valid Percent
Usia 27 100.0 100.0
19
Frequency Percent Valid Percent
Cumulative Percent
Kate gori Usia
2 7.4 7.4 7.4 27 100.0 100.0
<20 tahun 20-30 tahun 31-40 tahun 41-50 tahun 51-60 tahun 61-70 tahun >70 tahun Total Valid
Frequency Percent Valid Percent
Frequencies
[DataSet6] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Early onset.sav
Bakteri Penyebab VAP
4 14.8 14.8 14.8 13 48.1 48.1 63.0 7 25.9 25.9 88.9
1 3.7 3.7 92.6
1 3.7 3.7 96.3
1 3.7 3.7 100.0 27 100.0 100.0
E. coli Aci. baumanii K. pneumoniae S. maltophilia S. aureus Ps. aeruginos a Total
Valid
Frequency Percent Valid Percent
Cumulative Percent
Onset
19 70.4 70.4 70.4 8 29.6 29.6 100.0 27 100.0 100.0
cepat lambat Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Bakteri Penyebab VAP
4 21.1 21.1 21.1 11 57.9 57.9 78.9 4 21.1 21.1 100.0 19 100.0 100.0
E. coli Aci. baumanii K. pneumoniae Total
Valid
Frequency Percent Valid Percent
Frequencies
[DataSet1] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Late onset.sav
Frequency Table
[DataSet3] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Aci.baum.sav
Bakteri Penyebab VAP
2 25.0 25.0 25.0 3 37.5 37.5 62.5 1 12.5 12.5 75.0 1 12.5 12.5 87.5 1 12.5 12.5 100.0 8 100.0 100.0
Aci. baumanii K. pneumoniae S. maltophilia S. aureus Ps. aeruginos a Total
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ampilicin
1 7.7 7.7 7.7
12 92.3 92.3 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Amikacin
6 46.2 46.2 46.2 7 53.8 53.8 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftazidime
2 15.4 15.4 15.4 11 84.6 84.6 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Ciprofloxacin
2 15.4 15.4 15.4
1 7.7 7.7 23.1
10 76.9 76.9 100.0 13 100.0 100.0
sens itif intermediet resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftriaxone
1 7.7 7.7 7.7
1 7.7 7.7 15.4
11 84.6 84.6 100.0 13 100.0 100.0
sens itif intermediet resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefotaxime
1 7.7 7.7 7.7
1 7.7 7.7 15.4
11 84.6 84.6 100.0 13 100.0 100.0
sens itif intermediet resis ten Total Valid
Frequency Percent Valid Percent
Cumulative 13 100.0 +
Frequency Percent Valid Percent
Cumulative Percent
Cefepime
1 7.7 7.7 7.7
12 92.3 92.3 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Gentamicin
3 23.1 23.1 23.1 10 76.9 76.9 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Levofloxacin
3 23.1 23.1 23.1 3 23.1 23.1 46.2 7 53.8 53.8 100.0 13 100.0 100.0
sens itif intermediet resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Meropenem
4 30.8 30.8 30.8 9 69.2 69.2 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Piperacillin/Tazobactam
4 30.8 30.8 30.8 9 69.2 69.2 100.0 13 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Frequency Table
[DataSet5] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Ps.aeruginosa.sav
Amikacin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Aztreonam
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftazidime
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ciprofloxacin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftriaxone
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefepime
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Gentamicin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Meropenem
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ampicillin/Sulbactam
1 100.0 100.0 100.0 intermediet
Valid
Frequency Percent Valid Percent
Cumulative Percent
Trimethoprim/Sulfamethoxazole
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Tigecycline
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Piperacillin/Tazobactam
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Frequency Table
[DataSet4] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Klebsiella pneumoniae.sav
Ampilicin
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Amikacin
6 85.7 85.7 85.7 1 14.3 14.3 100.0 7 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Aztreonam
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftazidime
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ciprofloxacin
1 14.3 14.3 14.3 6 85.7 85.7 100.0 7 100.0 100.0
intermediet resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftriaxone
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cefotaxime
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefazolin
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
ESBL
4 57.1 100.0 100.0 3 42.9
7 100.0 +
Valid
System Missing
Total
Frequency Percent Valid Percent
Cumulative Percent
Ertapenem
5 71.4 71.4 71.4 2 28.6 28.6 100.0 7 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefepime
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Gentamicin
1 14.3 14.3 14.3 6 85.7 85.7 100.0 7 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Levofloxacin
1 14.3 14.3 14.3 6 85.7 85.7 100.0 7 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Meropenem
5 71.4 71.4 71.4 2 28.6 28.6 100.0 7 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ampicillin/Sulbactam
7 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Trimethoprim/Sulfamethoxazole
1 14.3 14.3 14.3 6 85.7 85.7 100.0 7 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Tigecycline
6 85.7 85.7 85.7 1 14.3 14.3 100.0 7 100.0 100.0
sens itif intermediet Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Piperacillin/Tazobactam
3 42.9 42.9 42.9 4 57.1 57.1 100.0 7 100.0 100.0
intermediet resis ten Total Valid
Frequency Percent Valid Percent
Frequencies
[DataSet3] C:\Users\user\Documents\KTI Dasta 2015\Olah data\E.coli Early.sav
Ampilicin
4 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Amikacin
4 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Aztreonam
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftazidime
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ciprofloxacin
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Ceftriaxone
1 25.0 25.0 25.0 3 75.0 75.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefotaxime
1 25.0 25.0 25.0 3 75.0 75.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefaz olin
1 25.0 25.0 25.0 3 75.0 75.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
ESBL
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
+ -Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefepime
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Gentamicin
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Levofloxacin
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Meropenem
3 75.0 75.0 75.0 1 25.0 25.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Ampicillin/Sulbactam
2 50.0 50.0 50.0 2 50.0 50.0 100.0 4 100.0 100.0
sens itif resis ten Total Valid
Frequency Percent Valid Percent
Cumulative Percent
Trimethoprim/Sulfamethoxazole
4 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Tigecycline
4 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative 4 100.0 100.0
sens itif intermediet resis ten Total Valid
Frequency Percent Valid Percent
Frequencies
[DataSet7] C:\Users\user\Documents\KTI Dasta 2015\Olah data\S.maltoph.sav
Ampilicin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Amikacin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Aztreonam
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftazidime
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ciprofloxacin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftriaxone
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cefepime
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Gentamicin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Levofloxacin
1 100.0 100.0 100.0 intermediet
Valid
Frequency Percent Valid Percent
Cumulative Percent
Meropenem
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ampicillin/Sulbactam
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Trimethoprim/Sulfamethoxazole
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Tigecycline
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Piperacillin/Tazobactam
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Frequencies
[DataSet8] C:\Users\user\Documents\KTI Dasta 2015\Olah data\S.aureus.sav
Ampilicin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Amoxicillin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Amikacin
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Aztreonam
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftazidime
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ciprofloxacin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cefmetazole
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ceftriaxone
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefotaxime
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
ESBL
1 100.0 100.0 100.0
-Valid
Frequency Percent Valid Percent
Cumulative Percent
Ertapenem
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Cefepime
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Gentamicin
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Levofloxacin
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Meropenem
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Ampicillin/Sulbactam
1 100.0 100.0 100.0 intermediet
Valid
Frequency Percent Valid Percent
Cumulative Percent
Trimethoprim/Sulfamethoxazole
1 100.0 100.0 100.0 resisten
Valid
Frequency Percent Valid Percent
Cumulative Percent
Tigecycline
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Cumulative Percent
Piperacillin/Tazobactam
1 100.0 100.0 100.0 sensitif
Valid
Frequency Percent Valid Percent
Patient
ID Testing Date Organism Name Onset AM AMC AMX AN ATM CAZ CIP CRO CTX CZ DOR ESB ETP FEP GM IPM LEV MEM SAM SXT TGC TZP
609028 8/2/2014 Esch.coli E R R S R R R R R R + S R R R S R S S I
610522 9/23/2014 Aci.baumannii E R R R R R R R R R I R R R S R
616020 8/15/2014 K.pneum.pneumoniae E R R S R R R R R R + S R R R S R R S I
616608 8/13/2014 Aci.baumannii E R R R R R R R R R I R R R S R
617840 8/13/2014 K.pneum.pneumoniae E R R S R R R R R R + S R S R S R R S R
595190 11/11/2014 K.pneum.pneumoniae L R S R R R R R R R R R R S I R
606159 12/1/2014 Steno.maltophilia L R R R R R R R R R I R R R S R
609469 12/30/2014 Staph.aureus L R R S S S R S S - S S S R S I R S S
611338 8/6/2014 Aci.baumannii L R R R R R R R R R I R R R S R
611696 9/17/2014 Aci.baumannii E R R S R R I R R R + S R R S S R R S S
611936 9/24/2014 Aci.baumannii E S S I S S S S S S S S S S S S
618956 8/6/2014 K.pneum.pneumoniae E R R R R R R R R R R R R S R
619931 10/16/2014 Esch.coli E R S R R R R R R R R R S S R
622877 7/16/2014 Aci.baumannii E R R S R R R S R S R S S
623746 10/17/2014 Esch.coli E R R S S R R S S S S S S
624873 11/19/2014 Aci.baumannii L R R R R R R R R R R R R R S S R
625344 12/2/2014 Esch.coli E R R S S S S S S S S S S S S S S S
628059 9/13/2014 Aci.baumannii E R R S S I I S S S S S S
606356 10/2/2014 Aci.baumannii E R R R R R R R R R R R R R S R
615868 7/2/2014 K.pneum.pneumoniae E R R S R R I R R R + S R R S S R R S I
616055 11/7/2014 Aci.baumannii E R R R R R R R R R R R R S R
620319 9/12/2014 Ps.aeruginosa L I R R R R R R R R S I R S R
617163 9/13/2014 Aci.baumannii E R R S R R R R R R - R R S R R S R S R
610851 12/1/2014 Aci.baumannii E R S R R R R R R R R R R R S R
619455 10/22/2014 Aci.baumannii E R R R R R R R R R R R R S R
611712 8/4/2014 K.pneum.pneumoniae L R R S R R R R R R + S R R R S R R S I
